Acquisitions significantly enhance the UAE’s local life sciences capabilities through strategic investments
Following the acquisition of KELIX bio, Mubadala Investment Company, an Abu Dhabi sovereign investor, has empowered its new specialty pharmaceutical business to acquire a 100 percent stake in four of GlobalOne Healthcare Holding’s (GHH) pharma assets which include Bioventure, Bioventure Healthcare, Gulf Inject and Wellpharma.
This…
